These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22425267)

  • 21. Pre-ICD illness beliefs affect postimplant perceptions of control and patient quality of life.
    Hallas CN; Burke JL; White DG; Connelly DT
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):256-65. PubMed ID: 20059710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and depressive symptoms in heart failure patients and their partners: the impact of role and gender.
    Luttik ML; Lesman-Leegte I; Jaarsma T
    J Card Fail; 2009 Sep; 15(7):580-5. PubMed ID: 19700134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
    Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator.
    Habibović M; van den Broek KC; Theuns DA; Jordaens L; Alings M; van der Voort PH; Pedersen SS
    Europace; 2011 Dec; 13(12):1723-30. PubMed ID: 21821854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience.
    Birnie DH; Sears SF; Green MS; Lemery R; Gollob MH; Amyotte B
    Europace; 2009 Jan; 11(1):26-30. PubMed ID: 19010798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.
    Bedair R; Babu-Narayan SV; Dimopoulos K; Quyam S; Doyle AM; Swan L; Gatzoulis MA; Wong T
    Int J Cardiol; 2015 Feb; 181():218-24. PubMed ID: 25528316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
    Chan PS; Hayward RA
    J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopathology in patients with ICDs over time: results of a prospective study.
    Kapa S; Rotondi-Trevisan D; Mariano Z; Aves T; Irvine J; Dorian P; Hayes DL
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):198-208. PubMed ID: 19930108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
    Chan PS; Chow T; Kereiakes D; Schloss EJ; Waller T; Eagle K; Hayward RA; Vijan S
    Arch Intern Med; 2006 Nov; 166(20):2228-33. PubMed ID: 17101941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
    Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
    Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient reported outcomes and quality of life in Chinese patients with implantable cardioverter defibrillators
    Guo X; Tripp C; Huber NL; Hou C; Lv R; Li J; Liang T; Sears SF
    Heart Lung; 2021; 50(1):153-158. PubMed ID: 32553697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors related to quality-of-life pattern changes in recipients of implantable defibrillators.
    Dickerson SS; Kennedy M; Wu YW; Underhill M; Othman A
    Heart Lung; 2010; 39(6):466-76. PubMed ID: 20561848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death.
    Carroll SL; Arthur HM
    Int J Nurs Stud; 2010 Jul; 47(7):836-45. PubMed ID: 20064639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators, induced anxiety, and quality of life.
    Sola CL; Bostwick JM
    Mayo Clin Proc; 2005 Feb; 80(2):232-7. PubMed ID: 15704778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator.
    Gibson DP; Kuntz KK; Levenson JL; Ellenbogen KA
    Europace; 2008 May; 10(5):540-4. PubMed ID: 18442964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.